Lazard Asset Management
FENC icon

Lazard Asset Management’s Fennec Pharmaceuticals FENC Stock Holding History

Lazard Asset Management’s Portfolio FENC Stock Details FENC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$177K Buy
+16,500
New +$135K ﹤0.01% 1689
2026
Q1 		– Sell
-13,121
Closed -$101K – 1941
2025
Q4 		$101K Buy
+13,121
New +$108K ﹤0.01% 1745
2024
Q4 		– Sell
-1,362
Closed -$6K – 2361
2024
Q3 		$6K Sell
1,362
-378
-22% -$2.19K ﹤0.01% 2046
2024
Q2 		$10K Buy
+1,740
New +$14.5K ﹤0.01% 2044

Other funds holding FENC

RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
SCM
Solas Capital Management Darien, Connecticut $187M AUM 12.91% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PCA
Prospect Capital Advisors Sausalito, California $220M AUM 60.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Lazard Asset Management's FENC Position: Q2 2026 in Review

Lazard Asset Management opened a new position in Fennec Pharmaceuticals (FENC) in Q2 2026: 16,500 shares worth $177K. The stake represents ﹤0.01% of the portfolio and ranks #1689 among its holdings. This is a return to the name: Lazard Asset Management previously reported a position in FENC as recently as Q4 2025.

Lazard Asset Management first reported a position in FENC in Q2 2024 and has held it in 4 quarters since. 105 funds tracked by Wall St. Rank hold FENC as of Q2 2026.

  • Lazard Asset Management held 16,500 shares of Fennec Pharmaceuticals worth $177K as of Q2 2026.
  • Fennec Pharmaceuticals was a new Lazard Asset Management position in Q2 2026.
  • Fennec Pharmaceuticals made up ﹤0.01% of Lazard Asset Management's portfolio in Q2 2026, its #1689 holding.
  • Lazard Asset Management first reported a position in Fennec Pharmaceuticals in Q2 2024 and has held it in 4 quarters since.
  • 105 funds tracked by Wall St. Rank held Fennec Pharmaceuticals as of Q2 2026.

Based on Lazard Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.